CYTOSEEK- Is Developing Technology To Enable The Next Generation Of Cell Therapies Against Solid Tumours By Augmenting Immune Cells
Our Artificial Membrane Binding Protein (AMBP) technology allows us to cover the surface of virtually any cell with therapeutic peptides, proteins, or enzymes that enhance the functionality of cells targeting solid tumours. AMBP technology is highly modular, comprising our proprietary humanlike anchoring domain, which binds non-specifically into membranes, and a functional domain to enhance the […]























